U.S. markets closed

Eurofins Scientific SE (ERF.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
67.55-1.24 (-1.80%)
At close: 5:35PM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close68.79
Open69.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range67.34 - 69.49
52 Week Range39.30 - 75.40
Volume290,242
Avg. Volume317,607
Market Cap12.885B
Beta (5Y Monthly)0.74
PE Ratio (TTM)67.55
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 03, 2019
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    All
    News
    Press Releases
    • Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches
      PR Newswire

      Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches

      Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The combined SARS-CoV-2 Plus Flu A/B and RSV tests are intended for the qualitative detection of SARS-CoV-2 and the quantitative detection of Influenza A, Influenza B, and RSV.

    • Eurofins Transplant Diagnostics Introduces TruGraf Liver At AASLD - The Liver Meeting
      PR Newswire

      Eurofins Transplant Diagnostics Introduces TruGraf Liver At AASLD - The Liver Meeting

      Transplant Genomics, Inc. ("TGI") a member of Eurofins Transplant Diagnostics, is excited to introduce TruGraf Liver, the only non-invasive blood-based test to assist in lowering immunosuppression in liver transplant patients, at The Liver Meeting Digital Experience ("The Liver Meeting"). The Liver Meeting is the annual meeting of the American Association for the Study of Liver Diseases, being held online November 13-16, 2020. In continuation of Eurofins Transplant's commitment to improving organ transplant outcomes worldwide, TruGraf Liver follows TruGraf®, the only non-invasive kidney rejection test reimbursed by CMS for the surveillance of "silent" sub-clinical acute rejection in patients with stable renal function.

    • Eurofins CDMO Announces Expansion of Drug Product Capabilities in Canada
      Business Wire

      Eurofins CDMO Announces Expansion of Drug Product Capabilities in Canada

      Eurofins CDMO announces the strategic expansion of its existing Drug Product operation capabilities with the early 2020 completion of its new Drug Product development and cGMP manufacturing facility, located in Mississauga, Canada.